Profil:
Synektik SASynektik medical shareholder sells 10 pct. stake in ABB at PLN 225 per share
Listed radiopharmaceuticals and medical solutions Synektik's shareholder Ksiazek Holding sold 852,913 shares, approx. 10 percent stake, at a price of PLN 225 (EUR 54.11) per share in an accelerated book-building (ABB) process, Synektik said in a market filing.
Following the settlement of the ABB, Ksiazek Holding will hold 1,376,143 Synektik shares, representing approximately 16.13 percent of the company's share capital.
The shareholder committed to a 180-day lock-up period for the shares held after the ABB, subject to standard exceptions.
The planned date for the transaction of the shares sold under the ABB is February 20, 2025.
ABB Santander Brokerage and Banco Santander acted as the exclusive global coordinator and book runner.
pr/ nl/